Ana Jiménez-Ubieto

9PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2025
The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Roberto García-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado

|Oct 10, 2025
Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study.

Irene Dogliotti, Sanne Tonino, Luana Conte

|Jun 20, 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group.

Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco

|Jun 30, 2023
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.

Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia

|Oct 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.

Ana Muntañola, Pablo Mozas, Santiago Mercadal

|Aug 09, 2022
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.

Ganimete Lamaj, Alberto Pablo-Trinidad, Ian Butterworth

Pageof 2

Frequent Collaborators

3 joint publications

Alejandro Martín García-Sancho

3 joint publications

Armando López-Guillermo

2 joint publications

Laura Magnano

2 joint publications

Juan-Manuel Sancho